Ariel Graff-Guerrero mainly focuses on Schizophrenia, Internal medicine, Psychiatry, Antipsychotic and Neuroscience. His work in Schizophrenia addresses issues such as Cognition, which are connected to fields such as Clinical psychology. His biological study spans a wide range of topics, including Endocrinology and Psychosis.
His research investigates the connection between Endocrinology and topics such as Agonist that intersect with problems in Radioligand and Globus pallidus. Particularly relevant to Risperidone is his body of work in Psychiatry. His studies in Antipsychotic integrate themes in fields like Positron emission tomography, Brief Psychiatric Rating Scale and Positive and Negative Syndrome Scale.
Schizophrenia, Internal medicine, Psychiatry, Antipsychotic and Neuroscience are his primary areas of study. His Schizophrenia research is multidisciplinary, incorporating elements of Positron emission tomography, Psychosis and Cognition. His Internal medicine research includes themes of Endocrinology and Oncology.
His Endocrinology study combines topics from a wide range of disciplines, such as Agonist and Glutamate receptor. His Psychiatry study typically links adjacent topics like Clinical psychology. His research integrates issues of Risperidone, Schizoaffective disorder and Brief Psychiatric Rating Scale in his study of Antipsychotic.
Ariel Graff-Guerrero focuses on Internal medicine, Schizophrenia, In patient, Antipsychotic and Dopamine. The study incorporates disciplines such as Endocrinology and Cardiology in addition to Internal medicine. His Schizophrenia research incorporates themes from Anterior cingulate cortex, Glutamatergic and Severity of illness.
The various areas that Ariel Graff-Guerrero examines in his Antipsychotic study include Glutamate receptor, Psychosis and Psychopathology, Clinical psychology. His Dopamine research entails a greater understanding of Neuroscience. He combines subjects such as Positron emission tomography and Emission computed tomography with his study of Dopamine receptor D2.
His main research concerns Schizophrenia, Internal medicine, Antipsychotic, In patient and Positive and Negative Syndrome Scale. The concepts of his Schizophrenia study are interwoven with issues in Glutamatergic, Receptor, Dopamine receptor D2, Anterior cingulate cortex and Neuroscience. His work in Neuroscience addresses subjects such as Insulin resistance, which are connected to disciplines such as Cognition.
His Internal medicine research is multidisciplinary, relying on both Positron emission tomography, Neuroimaging and Cardiology. His studies deal with areas such as Psychological intervention, Clozapine, Psychosis, Clinical psychology and Craving as well as Antipsychotic. His Positive and Negative Syndrome Scale study deals with the bigger picture of Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis.
American Journal of Psychiatry (2017)
Cerebral blood flow associated with creative performance: a comparative study
Rosa Aurora Chávez-Eakle;Ariel Graff-Guerrero;Ariel Graff-Guerrero;Juan-Carlos García-Reyna;Víctor Vaugier.
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
Camilo de la Fuente-Sandoval;Pablo León-Ortiz;Rafael Favila;Sylvana Stephano.
Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis: A Longitudinal Proton Magnetic Resonance Spectroscopy Study
Camilo de la Fuente-Sandoval;Pablo León-Ortiz;Mariana Azcárraga;Sylvana Stephano.
JAMA Psychiatry (2013)
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
Gagan Fervaha;Gagan Fervaha;Ariel Graff-Guerrero;Ariel Graff-Guerrero;Konstantine K. Zakzanis;George Foussias;George Foussias.
Journal of Psychiatric Research (2013)
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
Takefumi Suzuki;Gary Remington;Gary Remington;Benoit H. Mulsant;Benoit H. Mulsant;Hiroyuki Uchida;Hiroyuki Uchida.
Psychiatry Research-neuroimaging (2012)
Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain
Ariel Graff-Guerrero;Jorge González-Olvera;Ana Fresán;Diana Gómez-Martín.
Cognitive Brain Research (2005)
Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans : Effects of dopaminergic modulation
Mahesh Menon;Jimmy Jensen;Jimmy Jensen;Irina Vitcu;Ariel Graff-Guerrero.
Biological Psychiatry (2007)
The potential role of dopamine D3 receptor neurotransmission in cognition
Shinichiro Nakajima;Philip Gerretsen;Hiroyoshi Takeuchi;Hiroyoshi Takeuchi;Hiroyoshi Takeuchi;Fernando Caravaggio;Fernando Caravaggio.
European Neuropsychopharmacology (2013)
Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis.
Hiroyuki Uchida;Hiroyoshi Takeuchi;Ariel Graff-Guerrero;Takefumi Suzuki.
Journal of Clinical Psychopharmacology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: